ライフサイエンスコーパス: NOX4

1 n species-generating enzyme NADPH oxidase 4 (Nox4).

2 ting from the activation of NADPH oxidase 4 (NOX4).

3 ts with genetic deficiency (or silencing) of Nox4.

4 Co-IP) in HEK293 cells stably overexpressing NOX4.

5 ase, interacts with the C-terminal domain of NOX4.

6 xpression through the NADPH oxidase isoform, NOX4.

7 .-) production or the expression of Nox1 and Nox4.

8 n primary cardiomyocytes with a knockdown of Nox4.

9 most enriched pathways that were altered by Nox4.

10 nd blocks high glucose induction of Nox2 and Nox4.

11 demonstrate posttranslational regulation of Nox4.

12 n-proteasomal system-mediated degradation of Nox4.

13 ive signaling function of IP4 that regulates NOX4.

14 NADPH for binding and consequently inhibits NOX4.

15 dria act as an allosteric switch to activate NOX4.

16 d in at least two rodents and humans, making NOX4 a prime target for a first-in-class mechanism-based

17 O transcription factors and NADPH oxidase 4 (Nox4), a key regulator of reactive oxygen species produc

18 onfirmed to directly target NADPH oxidase 4 (NOX4), a reactive oxygen species generator known to dama

19 NADPH oxidase 4 (NOX4), a source of cellular superoxide anions, has multi

20 NADPH oxidase4 (NOX4), a target of miR-25, was significantly increased i

21 NOX4, a potent reactive oxygen species generator, was co

22 he development of cardiac arrhythmia, namely NOX4 activation, subsequent NOX4-specific NADPH-driven R

23 letal muscles or pharmacological blockade of Nox4 activity abrogated tumor-induced cachexia in mice.

24 Furthermore, we show that elevated NOX4 activity accelerates oxidation of NADH and supports

25 eta signaling, TGF-beta release from bone or Nox4 activity improved muscle function in mice with MDA-

26 s study we explored the role of constitutive Nox4 activity in regulating mitochondrial function.

27 olecule inhibitor resulted in attenuation of NOX4 activity, imbalanced redox status, and sensitized c

28 ls may have application for monitoring renal NOX4 activity.

29 ATP directly binds and negatively regulates NOX4 activity.

30 d inhibits iNOS and NADPH oxidase isoform 4 (NOX4), all of which are associated with oxidative stress

31 Here we discover that NAD(P)H oxidase 4 (NOX4), an enzyme known to catalyse the oxidation of NAD(

32 We aimed to investigate the role of Nox4, an endothelial generator of H2O2, in the regulatio

33 Both NOX4 and CD44v6 are up-regulated in the lungs of mice su

34 oteins is required for the ubiquitination of Nox4 and for maintaining low basal levels of this reacti

35 inhibits high glucose-induced expression of NOX4 and matrix protein and whether H2S and NO pathways

36 delayed manner relative to the induction of Nox4 and myofibroblast differentiation.

37 mice with fulvene-5, a specific inhibitor of NOX4 and NADPH oxidase 2 (NOX2), decreased their elevate

38 We investigated the role of Nox4 and Nox4-associated signaling pathways in the devel

39 se results indicate a critical role for both Nox4 and Nrf2 in counter-regulation of mitochondrial bio

40 We also observed that NOX4 and p22(phox) localize to the nuclear membrane in M

41 or TGF-beta-induced upregulation of p-MeCP2, NOX4 and primary miR-25, but downregulation of precursor

42 rkers for fibrosis (Ctgf), oxidative damage (Nox4) and haemodynamic load (Nppa).

43 d the ROS generation enzyme NADPH oxidase 4 (NOX4) and induced the activation of NF-E2-related factor

44 ical candidates (such as ADAMTS3, IL11RA and NOX4) and pathways (such as proteoglycan and glycosamino

45 smLRP1(-/-) main pulmonary artery (CTGF and NOX4) and reversed PAH in smLRP1(-/-) mice.

46 bited ROS generation enzyme NADPH oxidase 4 (NOX4), and increased dual specificity phosphatase 6 (DUS

47 The intestinal epithelium expresses NOX1, NOX4, and DUOX2, whose functions are not well understood

48 Ps included those in the DNMT2, DPEP1, FUT2, NOX4, and PON1 genes.

49 ding motif within the NADPH oxidase isoform, NOX4, and show that ATP directly binds and negatively re

50 mechanisms of transcriptional regulation of NOX4 are not well understood.

51 ole for stromally expressed NADPH oxidase 4 (NOX4) as a modulator of reactive oxygen species that in

52 oxygen species forming NADPH oxidase type 4 (Nox4) as a primary causal therapeutic target.

53 We investigated the role of Nox4 and Nox4-associated signaling pathways in the development of

54 d upregulation of the ROS-generating protein Nox4 at the ER-mitochondria contact sites (MAMs) is a pr

55 Thus, we conclude that targeting the Sirt1-Nox4 axis in muscles is an effective therapeutic interve

56 enesis of DPN and suggest that targeting LXR/Nox4 axis is a promising therapeutic approach.

57 milarly, skeletal muscle weakness, increased Nox4 binding to RyR1 and oxidation of RyR1 were present

58 development of therapeutic regimens aimed at NOX4 blockade.

59 Endothelial NOX4 breaks down the BBB, while neuronal NOX4 leads to n

60 The pharmacologic inhibition of NOX4 by either GKT137831, which is currently in phase 2

61 The Nox4 cardiac metabolome was then investigated by (1)H nu

62 or beta (TGF-beta), NADPH oxidase isoform 4 (Nox4), caspase-3 and Bax.

63 ly, we identified that IP4 competes with the NOX4 cofactor NADPH for binding and consequently inhibit

64 FYN and NOX4 colocalized in perinuclear mitochondria, ER, and nu

65 Moreover, low expression of NOX4 combined with high expression of either RhoC or Cdc

66 Calnexin also resided in NOX4-containing complexes as demonstrated by complexome

67 A significant increase in NOX4+ crypt epithelial cells was detected in VEH/SIV mac

68 In contrast, NOX4 deficiency did not inhibit the activation of the NL

69 as the increase in mitochondrial proteins in Nox4-deficient lung fibroblasts is inhibited by silencin

70 tic TNF-alpha and PCNA responses subsided in Nox4-deficient mice compared with wildtype mice.

71 Furthermore, Nox4-deficient mice showed substantial reduction in casp

72 enuated in primary hepatocytes isolated from Nox4-deficient mice.

73 ses in human hepatoma cells and wildtype and Nox4-deficient mice.

74 of oxidative-related genes, such as Rac1 and Nox4 demonstrated by both in vivo and in vitro studies.

75 ese data provide a novel mechanistic link of Nox4-dependent activation of mTORC2 via the energy senso

76 The goal of this study was to test Nox4-dependent ENaC regulation in two models: SS hyperte

77 However, the mechanisms by which NOX4-dependent metabolic regulation affect the innate im

78 The NOX4-dependent pathway regulates many factors essential

79 Moreover, the effect of Nox4 depletion was time-dependent; following six weeks o

80 IF-1alpha), downstream of NAD(P)H oxidase-4 (NOX4)-derived reactive oxygen species (ROS).

81 We provide evidence that NOX4-derived reactive oxygen species (ROS) inhibits P300

82 eam effector signaling pathways activated by Nox4-derived reactive oxygen species in the myocardium.

83 We speculate that miR-99b-mediated NOX4 downregulation may protect the intestinal epitheliu

84 We aimed to identify novel Nox4-driven cardioprotective mechanisms that promote ada

85 ecent studies have found that an increase in Nox4 during pressure overload protects the heart against

86 ric oxide synthase 2, NADPH oxidase (NOX) 2, NOX4, E-selectin, and monocyte chemotactic protein-1.

87 dependent protein kinase II was increased in NOX4 embryos but diminished by polyethylene glycol-conju

88 Intriguingly, NOX4 embryos developed cardiac arrhythmia that is charac

89 analyzed by an established LQ-1 program, the NOX4 embryos displayed much more variable beat-to-beat i

90 Both the phenotype and the increased ROS in NOX4 embryos were attenuated by NOX4 morpholino co-injec

91 at in control embryos versus 0.038 s/beat in NOX4 embryos).

92 Expression levels of Nox4-encoded mRNA and protein increased only in the diab

93 NADPH oxidase 4 (NOX4) enzyme, which catalyzes the reduction of O2 to hyd

94 ted with a significantly decreased number of NOX4+ epithelial cells in the intestines of THC-treated

95 Although necessary, MRTF is insufficient; Nox4 expression also requires TGFbeta-activated Smad3 an

96 High glucose increased NOX4 expression and activity at 24 h in renal proximal t

97 reduction in LXR expression and increase in Nox4 expression and activity in SCs and peripheral nerve

98 Hic-5 silencing induced constitutive Nox4 expression and enhanced TGF-beta1-inducible Nox4 le

99 I infusion to control mice increased cardiac Nox4 expression and induced fibrosis and hypertrophy.

100 , we observed a negative correlation between NOX4 expression and skeletal muscle fiber cross-sectiona

101 Moreover, MRTF inhibition prevents Nox4 expression during TGFbeta-induced fibroblast-myofib

102 NOX4 expression in cardiomyocytes (CMs) plays an importa

103 itant normalization of GSH concentration and Nox4 expression in diabetic mice.

104 , and that ATM inhibition leads to increased NOX4 expression in normal cells.

105 er capture microdissection reveals increased Nox4 expression in the tubular epithelium also during ob

106 TAZ/YAP mitigates injury-induced epithelial Nox4 expression in vitro and in vivo.

107 In HCC patients, NOX4 expression inversely correlates with RhoC and Cdc42

108 Moreover, NOX4 expression is associated with E-cadherin levels and

109 We showed that NOX4 expression levels are higher in A-T cells, and that

110 NaHS inhibition of high glucose-induced NOX4 expression was abrogated by N(omega)-nitro-l-argini

111 on via NADPH oxidase signaling, up-regulated Nox4 expression, and promoted NF-kappaB dependent promot

112 e-to-glutathione disulfide ratios, increased NOX4 expression, apoptosis and its executionary molecule

113 increases KLF5 expression, which stimulates NOX4 expression, ceramide accumulation, and causes DbCM.

114 d cardiac remodeling and robust elevation in Nox4 expression, indicating that AngII worsens cardiac i

115 generate NO to inhibit high glucose-induced NOX4 expression, oxidative stress, and matrix protein ac

116 tive effects of NaHS on high glucose-induced NOX4 expression, reactive oxygen species generation, and

117 ted transcription factor, decreases Nox2 and Nox4 expression, whereas NFAT overexpression increases N

118 nted NaHS inhibition of high glucose-induced NOX4 expression.

119 ons led to reduced superoxide production and NOX4 expression.

120 us cytoskeleton organization) could regulate Nox4 expression.

121 ardiac injury, at least in part by enhancing Nox4 expression.

122 eacetylation of NF-kappaB and suppression of NOX4 expression.

123 Inhibition of Nox4 expression/activity by genetic or pharmacological a

124 H) concentration and higher NADPH oxidase 4 (Nox4) expression, consistent with increased superoxide g

125 High-glucose increases NADPH oxidase 4 (NOX4) expression, reactive oxygen species generation, an

126 Our results suggest that endogenous NOX4 forms macromolecular complexes with calnexin, which

127 s a novel redox signaling pathway, involving Nox4-GADD34 interaction and a targeted oxidative inactiv

128 Importantly, NOX4 gene deletions are frequent in HCC patients, correl

129 es insights into the molecular mechanisms of NOX4 gene expression, informing novel therapeutic approa

130 y IL-6 was elevated, as was adipose Cox2 and Nox4 gene expressions, which may be associated with prom

131 in vivo in mice, and genetic ablation of the nox4 gene in mice, protected against perturbed lung flui

132 TGF-beta1-induced NOX4 gene promoter activation requires a region between

133 S site of the NOX4 promoter is essential for NOX4 gene transcription induced by TGF-beta1 in human lu

134 ranscriptional start site (TSS) of the human NOX4 gene were generated and their relative responsivene

135 nd reactive oxygen species (NADPH oxidase 4 (NOX4))-generating enzymes by classical activation pathwa

136 s, while expression values between SS and SS(Nox4-/-) groups were similar.

137 a expression in RCC cells, the NADPH oxidase NOX4 has been identified, but the pathogenic contributio

138 The NADPH oxidase (NOX) isoform NOX4 has been linked with diabetic kidney disease (DKD).

139 nduced in HSC by acetaldehyde treatment, and NOX4 has significantly increased mRNA half-life of CCR2

140 Inhibition of Nox4 has therapeutic potential to treat cardiac remodeli

141 NADPH oxidase 4 (Nox4) has been implicated in cardiac remodeling, but its

142 A preference for fatty acid oxidation in Nox4 hearts correlated with a better energetic state (ph

143 Cardiomyocyte-targeted Nox4 hearts preferentially oxidised fatty acids for ener

144 rtic arch endothelia exhibited elevated ROS, NOX4, HIF-1alpha, and glycolytic enzyme and PDK1 express

145 alpha, and IL-6 was significantly reduced in NOX4(HSCKO) compared to fl/fl mice.

146 c damage is due to an organ-specific role of NOX4 in blood-brain-barrier endothelial cells and neuron

147 mice showed increased expressions of PRR and NOX4 in both total kidney tissue and renal mitochondria

148 d serves as a negative feedback regulator of NOX4 in CMs during cardiac remodeling.

149 First, we showed that genetic ablation of Nox4 in Dahl salt-sensitive (SS) rat attenuated a high-s

150 approaches to interfere with upregulation of NOX4 in diseases characterized by activation of the TGF-

151 g miR-25 processing and thereby upregulating NOX4 in early diabetic nephropathy.

152 e examined the transcriptional regulation of NOX4 in human lung fibroblasts by TGF-beta1.

153 Knocking out Nox4 in skeletal muscles or pharmacological blockade of

154 oper maturation, processing, and function of NOX4 in the endoplasmic reticulum.

155 Upregulation of Nox4 in the myocardium causes cardiac remodeling through

156 2DM), we revealed the implication of LXR and Nox4 in the pathophysiology of DPN.

157 In this study we identified a novel role for Nox4 in the regulation of cardiac fatty acid oxidation.

158 Induction of Nox4 in vitro and in the podocyte-specific NOX4 transgen

159 activation of LXR or specific inhibition of Nox4 in vivo and in vitro to attenuate diabetes-induced

160 e report that podocyte-specific induction of NOX4 in vivo was sufficient to recapitulate the characte

161 xidative stress and reduced NAPDH oxidase 4 (NOX4) in glomeruli of diabetic eNOS(-/-) mice.

162 rk, we examined the role of NADPH oxidase 4 (Nox4) in LPS-induced TLR4 responses in human hepatoma ce

163 ed up-regulation of NADPH oxidase isoform 4 (NOX4) in patients with atrial fibrillation, which is acc

164 cies (ROS)-producing enzyme NADPH oxidase-4 (Nox4) in the pathogenesis of DPN.

165 ignaling platforms for Nox1 and Nox5 but not Nox4, in human VSMCs.

166 dant enzymes, including Gpxs, Prdx, Sod, and Nox4, in mediating this effect.

167 Inhibition of NOX4 increased CD8(+) T cells and restored responsivenes

168 Therefore, loss of NOX4 increases actomyosin levels and favours an epitheli

169 1 to 3) gene family as the closest target to Nox4 Indeed, when combining a NOS and a NOX inhibitor at

170 ereas NFAT overexpression increases Nox2 and Nox4, indicating that the CnAbeta/NFAT pathway modulates

171 2 at days 15 to 28 suppressed mTORC2 but not Nox4, induced smooth muscle-specific apoptosis in small

172 CMs, and FYN expression negatively regulated NOX4-induced O2- production and apoptosis in CMs.

173 sistance can be effectively overcome through NOX4 inhibition and could improve outcome in a broad ran

174 and diabetic mice and was attenuated by NOX1/NOX4 inhibition in diabetic mice.

175 Finally, NOX4 inhibition restored immunotherapy response in CAF-r

176 neuroprotective potential of pharmacological NOX4 inhibition was confirmed in an ex vivo model, free

177 uman tissue), and administration of the NOX1/NOX4 inhibitor increased glomerular FH levels in diabeti

178 Intervention with a NOX1/NOX4 inhibitor reduced albuminuria, glomerular hypertrop

179 ate levels were uniquely reduced by the NOX1/NOX4 inhibitor.

180 e glycol-conjugated superoxide dismutase, or NOX4 inhibitors fulvene-5, 6-dimethylamino-fulvene, and

181 Furthermore, the NADPH oxidase NOX4 inhibits this transition and therefore suppresses e

182 es are consequences of a so far unidentified NOX4-interacting protein.

183 The calnexin NOX4 interaction could be confirmed by reverse Co-IP and

184 In conclusion, NOX4 is a major mediator of diabetes-associated glomerul

185 We, therefore, conclude that Nox4 is a positive transcriptional regulator of CSE in e

186 ivation in PDAC development and suggest that NOX4 is a potential therapeutic target for PDAC.

187 NOX4 is critical for maintaining the immune-suppressive

188 Our results offer direct evidence that NOX4 is critical for renal tumorigenesis and they show h

189 beta-induced expression of the NADPH oxidase Nox4 is essential for fibroblast-myofibroblast transitio

190 In conclusion, NOX4 is induced in early alcoholic liver injury and regu

191 NOX4 is necessary to maintain parenchymal structures, in

192 Within the family of NADPH oxidases, NOX4 is unique as it is predominantly localized in the e

193 NADPH oxidase 4 (NOX4) is a member of the NADPH oxidase gene family that

194 e oxygen species-generating NADPH oxidase-4 (Nox4) is induced downstream of ATF4, binds to a PP1-targ

195 ge, the first evidence that NADPH oxidase 4 (NOX4) is involved in manifesting A-T disease.

196 NADPH oxidase 4 (NOX4) is the most abundant NOX isoform in the kidney; ho

197 Nox4 knockdown abrogates epithelial-myofibroblast transi

198 Both NOX4 knockout and NOX4betaKO mice exhibited impaired glu

199 We generated HSC-specific NOX4 KO mice and these were pair-fed on alcohol diet.

200 that only in the brain does NADPH oxidase 4 (NOX4) lead to ischemic damage.

201 ial NOX4 breaks down the BBB, while neuronal NOX4 leads to neuronal autotoxicity.

202 Nox4 levels and mTORC2 signaling were significantly upre

203 erebelli from A-T patients revealed elevated NOX4 levels.

204 expression and enhanced TGF-beta1-inducible Nox4 levels.

205 In hearts subjected to ischemia-reperfusion, Nox4 limits infarct size through this mechanism.

206 on studies showed that Nox1 and Nox5 but not Nox4, localize in cholesterol-rich fractions in VSMCs.

207 We find that NOX4 localizes to the inner mitochondria membrane and th

208 ude that, in A-T disease in humans and mice, NOX4 may be critical mediator and targeting it will open

209 We found that Nox4 mediated LPS-TLR4 signaling in hepatocytes via NF-k

210 Our results suggest that NOX4-mediated FAO promotes NLRP3 inflammasome activation

211 ata emphasize a critical contribution of the NOX4-mediated pathway in maladaptive upregulation of ENa

212 er injury has not been addressed, we studied NOX4-mediated regulation of CCR2/CCL2 mRNA stability.

213 Therefore, our data suggest that Nox4 mediates LPS-TLR4 signaling in human hepatoma cells

214 Nox4 mediates redox signaling at the MAM of stressed cel

215 eased ROS in NOX4 embryos were attenuated by NOX4 morpholino co-injection, treatments of the embryos

216 es with TGFbeta to facilitate MRTF-dependent Nox4 mRNA expression/promoter activation.

217 (TGF-beta1) is known to induce expression of NOX4 mRNA in mesenchymal cells.

218 NOX4 mRNA was significantly induced in patients with alc

219 ted a potential role for Hic-5 in regulating Nox4, myofibroblast differentiation, and senescence.

220 cleotide phosphatase] oxidase subunit 2) and NOX4 (NADPH [nicotinamide adenine dinucleotide phosphata

221 DPH oxidase (NOX)4 promoter and induction of NOX4 (NADPH oxidase 4) expression.

222 ologic inhibition [GKT137831 (Setanaxib)] of NOX4 "normalized" CAF to a quiescent phenotype and promo

223 gII-infused c-hNox4Tg mice with GKT137831, a Nox4/Nox1 inhibitor, abolished the increase in oxidative

224 Human VSMCs express Nox1, Nox4, Nox5 and Cav-1.

225 equences of five NOX genes (nox1, nox2/cybb, nox4, nox5, and duox) have been identified in the zebraf

226 The fast GSIS phase was absent from PIs from NOX4-null, beta-cell-specific knockout mice (NOX4betaKO)

227 NADPH oxidase 2 (Nox2) inhibition, but not Nox4 or Nox1 inhibition, attenuated LPS-induced superoxi

228 Nox2 silencing, but not Nox4 or Nox1 silencing, inhibited LPS-mediated inhibitor

229 arison of heart tissue from cardiac-targeted Nox4-overexpressing mice and controls.

230 gated the impact on the cardiac phenotype of NOX4 overexpression in zebrafish.

231 Lentiviral NOX4 overexpression or H(2)O(2) rescued GSIS in PIs from

232 Cardiac-targeted Nox4 overexpression profoundly remodelled the cardiac pr

233 Injection of NOX4-P437H mutant RNA had no effect on the cardiac pheno

234 characterized by activation of the TGF-beta1/NOX4 pathway.

235 Pharmacologic inhibition of NOX4 potentiates immunotherapy by overcoming CAF-mediate

236 instead, it triggered p38- and MK2-mediated, Nox4-promoted MRTF phosphorylation and activation.

237 n-provoked Nox4 protein and mRNA expression, Nox4 promoter activation, and reactive oxygen species pr

238 1 inducibility to the non-responsive -3.97kb NOX4 promoter construct.

239 Because the Nox4 promoter harbors a serum response factor/MRTF cis-e

240 b and 4.76kb upstream of the TSS site of the NOX4 promoter is essential for NOX4 gene transcription i

241 NOX4 promoter was induced in HSC by acetaldehyde treatme

242 eliminates the synergistic activation of the Nox4 promoter.

243 ated TGF-beta1 responsiveness of the -4.76kb NOX4 promoter.

244 ppresses TGFbeta/contact disruption-provoked Nox4 protein and mRNA expression, Nox4 promoter activati

245 hibited an approximately 10-fold increase in Nox4 protein expression and an 8-fold increase in the pr

246 on, and urinary albumin excretion as well as NOX4 protein expression and NADPH-dependent reactive oxy

247 response to calnexin shRNA reduced cellular NOX4 protein expression and reactive oxygen species form

248 ivities of myofibroblasts by down-regulating Nox4 protein expression.

249 The induction of constitutive Nox4 protein in Hic-5-silenced cells was independent of

250 We show that Nox4 protein is robustly induced in kidney tubular cells

251 NADPH oxidase 4 (Nox4) protein levels were increased in idiopathic PAH PA

252 d in both the renal cortex and medulla in SS(Nox4-/-) rats fed an HS diet.

253 ycemic animals was elevated in SS but not SS(Nox4-/-) rats.

254 how TGF-beta-1-induced CD44V6 regulates the NOX4/reactive oxygen species (ROS) signaling that mediat

255 We show that this Nox4-regulated pathway robustly enhances cell survival a

256 species-generating enzyme, NADPH oxidase 4 (Nox4), regulates a number of physiological and pathologi

257 Rho has been implicated in Nox4 regulation, but the underlying mechanisms are large

258 c understanding of the downstream effects of NOX4 remains to be established.

259 Activation of NOX4 requires catalytic subunit p22(phox), which is upre

260 Deletion of Nox4 rescued the exaggerated LV remodeling in FYN-defici

261 Here we show that deficiency of NOX4 resulted in reduced expression of carnitine palmito

262 ne destruction, upregulated NADPH oxidase 4 (Nox4), resulting in elevated oxidization of skeletal mus

263 One-cell stage embryos were injected with NOX4 RNA prior to video recording of a GFP-labeled (myl7

264 a1/TGFbetaRI signaling that acts to increase NOX4/ROS production, which is required for myofibroblast

265 Specifically, we found that NOX4/ROS regulates hyaluronan synthesis and the transcri

266 though not from NOX2 knockout mice) and from NOX4-silenced or catalase-overexpressing INS-1E cells.

267 Here, we report that NOX4 silencing in VHL-deficient RCC cells abrogates cell

268 Notably, NOX4 silencing or superoxide scavenging was sufficient t

269 NOX4 silencing suppressed Ca(2+) oscillations, and the p

270 Nox4 silencing suppressed LPS-induced TNF-alpha and PCNA

271 Finally, we show that NOX4 silencing, through PKM2, sensitizes cultured and ex

272 in diabetes by upregulation of mitochondria NOX4/SOD2/UCP2 signaling pathway.

273 rhythmia, namely NOX4 activation, subsequent NOX4-specific NADPH-driven ROS production, and redox-sen

274 hat observed in mesenchymal cell types, here NOX4 suppresses Rho and Cdc42 GTPase expression and down

275 al for renal tumorigenesis and they show how NOX4 suppression and VHL re-expression in VHL-deficient

276 /PKCzeta) and their disruption of attenuated Nox4 synthesis (76 +/- 9% reduction).

277 osphorylated p65 rel, which led to increased Nox4 synthesis.

278 at hyperglycemia stimulated NADPH oxidase 4 (Nox4) synthesis, and IGF-I facilitated its recruitment t

279 Vascular smooth muscle NOX4, the common denominator of ischemia within all isch

280 We found that LPS increased expression of Nox4, TNF-alpha, and proliferating cell nuclear antigen

281 uman endothelial cells in vitro demonstrated Nox4 to be a positive regulator of CSE transcription and

282 However, whether CD44V6 regulates NOX4 to mediate tissue repair and fibrogenesis is not we

283 ntified, but the pathogenic contributions of NOX4 to RCC have not been evaluated directly.

284 lectrophorese combined with SDS-PAGE yielded NOX4 to reside in macromolecular complexes.

285 We found NADPH oxidase isoform 4 (NOX4) to be the main producer of cytosolic H(2)O(2), whi

286 sphate 5-kinase 1alpha, and NADPH oxidase 4 (NOX4) to produce reactive oxygen species, driving intern

287 Cardiac-specific human Nox4 transgenic mice (c-hNox4Tg) were generated.

288 lpha and TGF-beta expression was observed in NOX4 transgenic mice and diabetic mice and was attenuate

289 phy we demonstrate that endothelial-specific Nox4 transgenic mice exhibit a hypo-contractile phenotyp

290 al cells, isolated from endothelial-specific Nox4 transgenic mice, compared with wild-type littermate

291 f Nox4 in vitro and in the podocyte-specific NOX4 transgenic mouse led to reduced FH levels.

292 nine ratio and the renal expressions of PRR, NOX4, UCP2, caspase3, phos-FOXO3a, phos-NF-kappaB, colla

293 rial reactive oxygen species production, and Nox4 upregulation.

294 at direct phosphorylation of tyrosine 566 on NOX4 was critical for this FYN-mediated negative regulat

295 Mechanistically, NOX4 was induced through p16-Rb-regulated E2F and p22(ph

296 Protein levels of p-MeCP2, HIPK2, and NOX4 were increased in high glucose (HG)- or TGF-beta-tr

297 of a ROS-generating enzyme, NADPH oxidase 4 (NOX4), which promotes cisplatin-resistant tumor growth.

298 geting, focusing on the ROS-producing enzyme NOX4, which is upregulated by CAF in many human cancers,

299 re partially abrogated by down-regulation of NOX4 with siRNA.

300 higher levels of NOX5-but not NOX1, NOX2, or NOX4-with a bimodal distribution correlating with diseas